All Clinical Trials:
Oncology Clinical Trial: Can Video Testimonials Benefit Adolescents with Cancer?
Clinical Trial | Adolescents and Young Adults, Supportive Care | Contact (714) 509-8646
Oncology Clinical Trial: Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Clinical Trial Protocol # AALL1331 | Leukemia/Lymphoma, Recurrent/Refractory Cancer | Contact (714) 509-8646
Oncology Clinical Trial: A Multi-Center Study Evaluating KTE-C19 in Pediatric and Adolescent Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
Clinical Trial | Adolescents and Young Adults, Leukemia/Lymphoma, Recurrent/Refractory Cancer | Contact (714) 509-8646
Oncology Clinical Trial: Study of Selinexor in Pediatric Solid Tumors
Clinical Trial Protocol # ADVL1414 | Brain Tumor/Central Nervous System/Neuro-Oncology, Recurrent/Refractory Cancer, Solid Tumors | Contact (714) 509-8646
Oncology Clinical Trial: Study of response of lymphomas and leukemias to standard chemotherapies in patients with Biallelic Mismatch Repair Deficiencies (BMMRD)
Clinical Trial | Biology/Genomics, Leukemia/Lymphoma | Contact (714) 509-8646
Oncology Clinical Trial: Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia
Clinical Trial Protocol # AAML1331 | Leukemia/Lymphoma | Contact (714) 509-8646
Oncology Clinical Trial: Fertility Understanding through Registry and Evaluation (FUTuRE Fertility)
Clinical Trial | Adolescents and Young Adults, Fertility, Registry | Contact (714) 509-8646
Oncology Clinical Trial: A Study of Ramucirumab (LY3009806) in Children With Refractory Solid Tumors
Clinical Trial Protocol # ADVL1416 | Brain Tumor/Central Nervous System/Neuro-Oncology, Recurrent/Refractory Cancer, Solid Tumors | Contact (714) 509-8646
Oncology Clinical Trial: Project – Every Child for Younger Patients With Cancer
Clinical Trial Protocol # APEC14B1 | Biology/Genomics, Registry | Contact (714) 509-8646
Oncology Clinical Trial: Lorvotuzumab Mertansine in Treating Younger Patients With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma
Clinical Trial Protocol # ADVL1522 | Recurrent/Refractory Cancer, Solid Tumors | Contact (714) 509-8646
Oncology Clinical Trial: Glembatumumab Vedotin in Treating Patients With Recurrent or Refractory Osteosarcoma
Clinical Trial Protocol # AOST1521 | Recurrent/Refractory Cancer, solid Tumors | Contact (714) 509-8646
Oncology Clinical Trial: A Study on Drug Monitoring of Asparaginase Activity in Pediatric Patients with Acute Lymphoblastic Leukemia
Clinical Trial | Biology/Genomics, Leukemia/Lymphoma | Contact (714) 509-8646
Oncology Clinical Trial: Dinutuximab in Combination With Sargramostim in Treating Patients With Recurrent Osteosarcoma
Clinical Trial Protocol # AOST1421 | Recurrent/Refractory Cancer, Solid Tumors | Contact (714) 509-8646
Oncology Clinical Trial: Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease
Clinical Trial Protocol #CMX001-351 | Supportive Care | Contact (714) 509-8646
Oncology Clinical Trial: A Study of Pembrolizumab (MK-3475) in Pediatric Participants With Advanced Melanoma or Advanced, Relapsed, or Refractory PD-L1-Positive Solid Tumors or Lymphoma (MK-3475-051/KEYNOTE-051)
Clinical Trial Protocol # MK3475-051/ADVL1621 | Adolescents and Young Adults, Recurrent/Refractory Cancer, Solid Tumors | Contact (714) 509-8646
Oncology Clinical Trial: Vincristine Sulfate Liposome Injection (Marqibo®) in Combination With UK ALL R3 Induction Chemotherapy for Children, Adolescents, and Young Adults With Relapsed ALL
Clinical Trial Protocol #T2012-002 | Adolescents and Young Adults, Leukemia/Lymphoma, Recurrent/Refractory Cancer | Contact (714) 509-8646
Oncology Clinical Trial: Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome
Clinical Trial Protocol #: AAML1531 | Leukemia/Lymphoma | Contact (714) 509-8646
